[Multidisciplinary Consensus for the Monitoring and Control of Asthma Through Telemedicine. The COMETA Project]

Carlos Almonacid Sánchez, Marina Blanco Aparicio, Javier Domínguez Ortega, Jordi Giner Donaire, Jesús Molina Paris, Navidad Sánchez Marcos, Vicente Plaza, Carlos Almonacid Sánchez, Marina Blanco Aparicio, Javier Domínguez Ortega, Jordi Giner Donaire, Jesús Molina Paris, Navidad Sánchez Marcos, Vicente Plaza

Abstract

Despite the therapeutic advances currently available, asthma control is poor. Such control is based on assessing the patient, adjusting treatment, and reviewing the response to treatment. In normal situations, asthma is monitored and controlled by sequential face-to-face visits. However, due to biosecurity and distancing measures to avoid disease transmission during a pandemic, such monitoring and control is limited. This is how tele-assistance, which is available from extensive published evidence in asthma, has emerged. Even so, it should not be understood as a substitute for face-to-face consultations, but as a complementary alternative to them, in which patients can be monitored when a face-to-face consultation is not necessary or cannot be carried out. Through the COMETA project (COntrol como Meta en la Era de la Telemedicina en el Asma, Control as a Goal in the Age of Telemedicine in Asthma), a group of experts addressed in depth the asthmatic pathology, analyzing in detail the existing problems in order to achieve control and propose solutions to situations such as those we are currently experiencing with the COVID-19 pandemic.

Keywords: Asthma; Control; Protocol; Telemedicine.

© 2021 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.

Figures

Figura 1
Figura 1
Algoritmo de actuación para el proyecto COMETA.

References

    1. Criterios de derivación en asma. Documento de consenso [consultado 4 Dic 2020] Disponible en:
    1. Partridge M.R., van der Molen T., Myrseth S.E., Busse W.W. Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study. BMC Pulm Med. 2006;6:13.
    1. Price D., Fletcher M., van der Molen T. Asthma control and management in 8,000 European patients: The REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009.
    1. Olaguibel J.M., Quirce S., Julia B., Fernandez C., Fortuna A.M., Molina J., et al. Measurement of asthma control according to Global Initiative for Asthma guidelines: A comparison with the Asthma Control Questionnaire. Respir Res. 2012;13:50.
    1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention [consultado 4 Dic 2020] Disponible en:
    1. Olaguibel J.M., Alobid I., Álvarez Puebla M., Crespo-Lessmann A., Domínguez Ortega J., García-Rio F., et al. Upper and lower airways functional examination in asthma and respiratory allergic deseases. Considerations in the SARS-CoV-2 post-pandemic situation. J Investig Allergol Clin Immunol. 2021;31:17–35.
    1. Guía Española para el Manejo del Asma (GEMA) 5.0 [consultado 4 Dic 2020] Disponible en:
    1. Plaza V., Fernández-Rodríguez C., Melero C., Cosío B.G., Entrenas L.M., de Llano L.P., et al. Validation of the’Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016;29:142–152.
    1. Plaza V., Giner J., Curto E., Alonso Ortiz M.B., Orue M.I., Vega J.M., et al. Assessing Adherence by Combining the Test of Adherence to Inhalers with Pharmacy Refill Records. J Investig Allergol Clin Immunol. 2021;31:58–64.
    1. Plaza V., Giner J., Calle M., Rytila P., Campo C., Ribo P., et al. Impact of patient satisfaction with his or her inhaler on adherence and asthma control. Allergy Asthma Proc. 2018;39:437–444.
    1. Hare N., Bansal P., Bajowala S.S., Abramson S.L., Chervinskiy S., Corriel R., et al. Work Group Report: COVID-19: Unmasking Telemedicine. J Allergy Clin Immunol Pract. 2020;8:2461–2473.
    1. Chongmelaxme B., Lee S., Dhippayom T., Saokaew S., Chaiyakunapruk N., Dilokthornsakul P. The effects of telemedicine on asthma control and patients’ quality of life in adults: A systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7:199–216.
    1. Almonacid C, Plaza V. Guía SEPAR para la teleconsulta de pacientes respiratorios [consultado 4 Dic 2020] Disponible en:
    1. Directiva 2011/24/UE del Parlamento Europeo y del Consejo, de 9 de marzo de 2011, relativa a la aplicación de los derechos de los pacientes en la asistencia sanitaria transfronteriza [consultado 4 Dic 2020] Disponible en: 32011L0024
    1. Consejo General de Colegios Oficiales de Médicos. Marco legal aplicable a la telemedicina en la UE [consultado 4 Dic 2020] Disponible en:
    1. Ministerio de la Presidencia Relaciones con las Cortes y Memoria Democrática. Real Decreto-ley 8/2020, de 17 de marzo, de medidas urgentes extraordinarias para hacer frente al impacto económico y social del COVID-19 [consultado 4 Dic 2020] Disponible en:
    1. Ministerio de la Presidencia Relaciones con las Cortes y Memoria Democrática. Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales [consultado 4 Dic 2020] Disponible en:
    1. Ministerio de la Presidencia Relaciones con las Cortes y Memoria Democrática. Ley 41/2002, de 14 de noviembre, básica reguladora de la autonomía del paciente y de derechos y obligaciones en materia de información y documentación clínica [consultado 4 Dic 2020] Disponible en:
    1. Comisión Central de Deontología. La telemedicina en el acto médico. Consulta médica no presencial, e-consulta o consulta online [consultado 4 Dic 2020] Disponible en:
    1. Dokbua S., Dilokthornsakul P., Chaiyakunapruk N., Saini B., Krass I., Dhippayom T. Effects of an asthma self-management support service provided by community pharmacists: A systematic review and meta-analysis. J Manag Care Spec Pharm. 2018;24:1184–1196.
    1. Kovacevic M., Culafic M., Jovanovic M., Vucicevic K., Kovacevic S.V., Miljkovic B. Impact of community pharmacists’ interventions on asthma self-management care. Res Social Adm Pharm. 2018;14:603–611.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera